Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-6-12
|
pubmed:abstractText |
Testosterone induces susceptibility to Plasmodium chabaudi malaria by imposing restrictions on those mechanisms which mediate resistance controlled by genes of the H-2 complex and the non-H-2 background in mice. This study investigated whether these restrictions are abolished after withdrawal of testosterone. Female mice of the inbred strain C57BL/10 were treated with 0.9 mg testosterone twice a week for 3 weeks and testosterone was then withdrawn for 12 weeks. The treatment raised plasma testosterone levels from 0.18 ng/ml to 3.79 ng/ml. After the testosterone treatment, these levels progressively dropped and reached 0.21 ng/ml by week 12 after testosterone withdrawal. Surprisingly, however, the testosterone-induced susceptibility still persisted. When mice were challenged on week 12 after testosterone withdrawal, P. chabaudi infections were still fatal in testosterone-treated mice, in contrast to self-healing infections in resistant, i.e. untreated, control mice. In addition, testosterone caused a persistent decrease in the levels of total IgG antibodies, especially IgG1 and IgG2b isotypes. In contrast, testosterone-induced changes in spleen cells, such as the reduction in number by 50%, the relative increase in CD8+ cells and the decrease in Ig+ cells, as well as the acquisition of the susceptible phenotype, were completely reversed on week 10 after testosterone withdrawal at the latest. Testosterone did not affect the production of the TH1-signalling cytokine interferon-gamma and the TH2-signalling cytokines interleukin (IL)-4 and IL-10 in response to P. chabaudi malaria. Together, our data indicated that the gene-controlled host resistance to P. chabaudi malaria is subject to superior hormonal imprinting: when once induced by testosterone, mechanisms which suppress resistance thus causing susceptibility persist independently of testosterone.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Protozoan,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-0795
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
275-81
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:9166117-Animals,
pubmed-meshheading:9166117-Antibodies, Protozoan,
pubmed-meshheading:9166117-Cells, Cultured,
pubmed-meshheading:9166117-Disease Susceptibility,
pubmed-meshheading:9166117-Female,
pubmed-meshheading:9166117-Immunoglobulin G,
pubmed-meshheading:9166117-Interferon-gamma,
pubmed-meshheading:9166117-Interleukin-10,
pubmed-meshheading:9166117-Interleukin-4,
pubmed-meshheading:9166117-Malaria,
pubmed-meshheading:9166117-Mice,
pubmed-meshheading:9166117-Mice, Inbred C57BL,
pubmed-meshheading:9166117-Plasmodium chabaudi,
pubmed-meshheading:9166117-T-Lymphocytes,
pubmed-meshheading:9166117-Testosterone,
pubmed-meshheading:9166117-Time Factors
|
pubmed:year |
1997
|
pubmed:articleTitle |
Testosterone-induced susceptibility to Plasmodium chabaudi malaria: persistence after withdrawal of testosterone.
|
pubmed:affiliation |
Division of Molecular Parasitology, Heinrich Heine University, Düsseldorf, Germany.
|
pubmed:publicationType |
Journal Article
|